Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder
2009 ◽
Vol 31
(12)
◽
pp. 2851-2859
◽
Keyword(s):
Keyword(s):
2003 ◽
Vol 10
(2)
◽
pp. 162-173
◽
Keyword(s):
Keyword(s):
Keyword(s):
1999 ◽
Vol 8
(4)
◽
pp. 328-332
◽
Keyword(s):
Keyword(s):
Keyword(s):